Home > > > > Report Detail

Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential

Publisher Name :
Date: 07-Oct-2019
No. of pages: 310

The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025.

The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period:


  • Increased Disease Awareness

  • Approval/launches of the New Vaccines

  • Rising focus on immunization programs

  • Increasing government support for the vaccine development


Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis and recent development.

Other emerging players are making novel technology-based vaccines which are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases which are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens and recent development.

Key Topics Covered in the Report:


  • The Market Size of the Global Human Vaccines Market

  • The Market Size of the Global Pediatric Vaccines Market

  • The Market Size of the Global Adult Vaccines Market

  • The Market Size of the 42 Leading Vaccines

  • The Market Size of the Pneumococcal Disease, Diphtheria, Tetanus and Pertussis (DTP), Influenza, Human Papilloma Virus (HPV), Meningococcal, Hepatitis, Measles, Mumps, and Rubella (MMR), Rotavirus, Varicella.

  • Thoroughly Evaluates Market Share of the Segments such as Disease Indications, End Users, Leading Vaccines, and Companies

  • Investigates the Key Growth Drivers and Restraints of the Global Human Vaccines Market

  • Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement

  • A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development

  • An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Platform Technology, and Recent Development


Detailed Segmentation:

Global Human Vaccines Market, By Disease Indication


  • Influenza

  • Meningococcal

  • Hepatitis

  • Rotavirus

  • Varicella

  • Pneumococcal Disease

  • Diphtheria, Tetanus and Pertussis (DTP)

  • Measles, Mumps, and Rubella (MMR)

  • Human Papilloma Virus (HPV)


Global Human Vaccines Market, By End User


  • Pediatric Vaccines

  • Adult Vaccines


Global Human Vaccines Market, By Leading Vaccines


  • Prevnar / Prevnar 13

  • Gardasil / Gardasil 9

  • Vaxigrip

  • Fluzone

  • Flublok

  • Varivax

  • Menactra

  • Proquad

  • Pneumovax 23

  • Fluarix/FluLaval

  • Havrix/Twinrix/Engerix–B

  • Priorix, Priorix Tetra, Varilrix

  • M–M–R II

  • Adacel

  • Boostrix

  • Bexsero

  • Menveo

  • Cervarix

  • Trumenba

  • Shingrix

  • Pentacel, Pentaxim, Imovax, Hexaxim

  • Rotateq

  • Zostavax

  • Rotarix

  • Synflorix

  • Pediarix, Infanrix

  • Ticovac

  • Biken Ha

  • Tetrabik

  • Mearubik

  • Varicella (MTP)

  • Jebik V

  • Flumist/Fluenz

  • Bio Thrax

  • Dukoral

  • Ixiaro

  • In Live

  • HeaLive

  • BiLive

  • Anflu

  • EasySix

  • Imvamune


Global Human Vaccines Market, By Key Players


  • Sanofi Pasteur

  • GlaxoSmithKline (GSK)

  • Merck

  • Pfizer

  • AstraZeneca

  • Mitsubishi Tanabe Pharma

  • Emergent Biosolutions

  • Astellas Pharma Inc.

  • Valneva

  • Seqirus

  • Bavarian Nordic

  • Sinovac

  • Panacea Biotec

  • Bharat Biotech

  • Serum Institute of India

  • Biological E. Limited


Global Human Vaccines Market, By Emerging Players


  • Vaccitech

  • Janssen (Johnson & Johnson)

  • Novavax

  • VBI Vaccines

  • GeoVax

  • Moderna Inc

  • Biondvax

  • Integrated Biotherapeutics Inc

  • GeneOne Life Science

  • Profectus BioSciences

  • Pneumagen

  • Themis Bioscience

  • Xeme Biopharma Inc

  • Altimmune

  • Pfenex Inc

  • Northwest Biotherapeutics

  • OncBioMune Pharmaceuticals


The Report Helps Answer the Following Questions:


  • What is the current size of the overall global human vaccines market? How much will this market be worth from 2019 to 2025?

  • What are the market shares of the leading segments of the global human vaccines market in 2018?

  • What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025?

  • What are the main drivers and restraints in the global human vaccines market?

  • What are the leading vaccines? What are their revenue potentials to 2025?

  • What are the major deals happenings in the global vaccines market?

  • Who are the leading companies and what are their activities, revenue, recent developments and prospects?

  • What are some of the most prominent human vaccines currently in development? What are their activities, platform technology and recent developments?

  • What are new diseases areas which the vaccines companies are exploring?

Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential

Table of Contents

1. Executive Summary

2. Global Vaccines Market Size & Forecast (2015 – 2025)

3. Market Share Analysis of Global Vaccines Market (%)
3.1 Global Vaccines Market Share, By Disease
3.2 Global Vaccines Market Share, By End User
3.3 Global Vaccines Market Share, By Leading Vaccine
3.4 Global Vaccines Market Share, By Company

4. Global Vaccines Market – Key Market Dynamics
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. Global Vaccines Market, By Disease
5.1 Pneumococcal Disease
5.2 Diphtheria, Tetanus and Pertussis (DTP)
5.3 Influenza
5.4 Human Papilloma Virus (HPV)
5.5 Meningococcal
5.6 Hepatitis
5.7 Measles, Mumps, and Rubella (MMR)
5.8 Rotavirus
5.9 Varicella
5.10 Other Diseases

6. Global Vaccines Market, By End User
6.1 Pediatric Vaccines
6.2 Adult Vaccines

7. Global Vaccines Market, By Leading Vaccine
7.1 Prevnar / Prevnar 13
7.2 Gardasil / Gardasil 9
7.3 Vaxigrip
7.4 Fluzone
7.5 Flublok
7.6 Varivax
7.7 Menactra
7.8 Proquad
7.9 Pneumovax 23
7.10 Fluarix/FluLaval
7.11 Havrix/Twinrix/Engerix–B
7.12 Priorix, Priorix Tetra, Varilrix
7.13 M–M–R II
7.14 Adacel
7.15 Boostrix
7.16 Bexsero
7.17 Menveo
7.18 Cervarix
7.19 Trumenba
7.20 Shingrix
7.21 Pentacel, Pentaxim, Imovax, Hexaxim
7.22 Rotateq
7.23 Zostavax
7.24 Rotarix
7.25 Synflorix
7.26 Pediarix,Infanrix
7.27 Ticovac
7.28 Biken Ha
7.29 Tetrabik
7.30 Mearubik
7.31 Varicella (MTP)
7.32 Jebik V
7.33 Flumist/Fluenz
7.34 BioThrax
7.35 Dukoral
7.36 Ixiaro
7.37 InLive
7.38 HeaLive
7.39 BiLive
7.40 Anflu
7.41 EasySix
7.42 Imvamune
7.43 Other Vaccines

8. Major Deals and Agreement Happenings in the Global Vaccines Market
8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement
8.6 Partnerships

9. Key Players in the Global Vaccines Market
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Vaccines Portfolio
9.1.3 Vaccines Market Value Analysis & Forecast
9.1.4 Promising Vaccines in the Clinical Development
9.1.5 Recent Development
9.2 GlaxoSmithKline (GSK)
9.2.1 Business Overview
9.2.2 Vaccines Portfolio
9.2.3 Vaccines Market Value Analysis & Forecast
9.2.4 Promising Vaccines in the Clinical Development
9.2.5 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Vaccines Portfolio
9.3.3 Vaccines Market Value Analysis & Forecast
9.3.4 Promising Vaccines in the Clinical Development
9.3.5 Recent Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Vaccines Portfolio
9.4.3 Vaccines Market Value Analysis & Forecast
9.4.4 Promising Vaccines in the Clinical Development
9.4.5 Recent Development
9.5 AstraZeneca
9.5.1 Business Overview
9.5.2 Vaccines Portfolio
9.5.3 Vaccines Market Value Analysis & Forecast
9.5.4 Recent Development
9.6 Mitsubishi Tanabe Pharma
9.6.1 Business Overview
9.6.2 Vaccines Portfolio
9.6.3 Vaccine Market Value Analysis & Forecast
9.6.4 Promising Vaccines in the Clinical Development
9.6.5 Recent Development
9.7 Emergent BioSolutions
9.7.1 Business Overview
9.7.2 Vaccines Portfolio
9.7.3 Vaccine Market Value Analysis & Forecast
9.7.4 Promising Vaccines in the Clinical Development
9.7.5 Recent Development
9.8 Astlellas Pharma Inc
9.8.1 Business Overview
9.8.2 Vaccines Portfolio
9.8.3 Vaccines Market Value Analysis & Forecast
9.8.4 Recent Development
9.9 Valneva
9.9.1 Business Overview
9.9.2 Vaccines Portfolio
9.9.3 Vaccines Market Value Analysis & Forecast
9.9.4 Promising Vaccines in the Clinical Development
9.9.5 Recent Development
9.10 Seqirus
9.10.1 Business Overview
9.10.2 Vaccines Portfolio
9.10.3 Vaccine Market Value Analysis & Forecast
9.10.4 Promising Vaccines in the Clinical Development
9.10.5 Recent Development
9.11 Bavarian Nordic
9.11.1 Business Overview
9.11.2 Vaccines Portfolio
9.11.3 Vaccine Market Value Analysis & Forecast
9.11.4 Promising Vaccines in the Clinical Development
9.11.5 Recent Development
9.12 Sinovac
9.12.1 Business Overview
9.12.2 Vaccines Portfolio
9.12.3 Vaccine Market Value Analysis & Forecast
9.12.4 Promising Vaccines in the Clinical Development
9.12.5 Recent Development
9.13 Panacea Biotec
9.13.1 Business Overview
9.13.2 Vaccines Portfolio
9.13.3 Vaccine Market Value Analysis & Forecast
9.13.4 Promising Vaccines in the Clinical Development
9.13.5 Recent Development
9.14 Bharat Biotech
9.14.1 Business Overview
9.14.2 Vaccines Portfolio
9.14.3 Promising Vaccines in the Clinical Development
9.14.4 Recent Development
9.15 Serum Institute of India
9.15.1 Business Overview
9.15.2 Vaccines Portfolio
9.15.3 Promising Vaccines in Clinical Development
9.15.4 Recent Development
9.16 Biological E. Limited
9.16.1 Business Overview
9.16.2 Vaccines Portfolio
9.16.3 Promising Vaccines in Clinical Development
9.16.4 Recent Development

10. Emerging Players in the Global Vaccines Market
10.1 Vaccitech
10.1.1 Business Overview
10.1.2 Promising Vaccines in the Clinical Development
10.1.3 Recent Development
10.2 Janssen (Johnson& Johnson)
10.2.1 Business Overview
10.2.2 Promising Vaccines in the Clinical Development
10.2.3 Recent Development
10.3 Novavax
10.3.1 Business Overview
10.3.2 Promising Vaccines in the Clinical Development
10.3.3 Recent Development
10.4 VBI Vaccines
10.4.1 Business Overview
10.4.2 Promising Vaccines in the Clinical Development
10.4.3 Recent Development
10.5 GeoVax
10.5.1 Business Overview
10.5.2 Promising Vaccines in the Clinical Development
10.5.3 Recent Development
10.6 Moderna Inc
10.6.1 Business Overview
10.6.2 Promising Vaccines in the Clinical Development
10.6.3 Recent Development
10.7 Biondvax
10.7.1 Business Overview
10.7.2 Promising Vaccines in the Clinical Development
10.7.3 Recent Development
10.8 Integrated Biotherapeutics Inc
10.8.1 Business Overview
10.8.2 Promising Vaccines in the Clinical Development
10.8.3 Recent Development
10.9 GeneOne Life Science
10.9.1 Business Overview
10.9.2 Promising Vaccines in the Clinical Development
10.9.3 Recent Development
10.10 Profectus BioSciences
10.10.1 Business Overview
10.10.2 Promising Vaccines in the Clinical Development
10.10.3 Recent Development
10.11 Pneumagen
10.11.1 Business Overview
10.11.2 Promising Vaccines in the Clinical Development
10.11.3 Recent Development
10.12 Themis Bioscience
10.12.1 Business Overview
10.12.2 Promising Vaccines in the Clinical Development
10.12.3 Recent Development
10.13 Xeme Biopharma Inc
10.13.1 Business Overview
10.13.2 Promising Vaccines in the Clinical Development
10.13.3 Recent Development
10.14 Altimmune
10.14.1 Business Overview
10.14.2 Promising Vaccines in the Clinical Development
10.14.3 Recent Development
10.15 Pfenex Inc
10.15.1 Business Overview
10.15.2 Promising Vaccines in the Clinical Development
10.15.3 Recent Development
10.16 Northwest Biotherapeutics
10.16.1 Business Overview
10.16.2 Promising Vaccines in the Clinical Development
10.16.3 Recent Development
10.17 OncBioMune Pharmaceuticals
10.17.1 Business Overview
10.17.2 Promising Vaccines in the Clinical Development
10.17.3 Recent Development

List of Tables:

Table 9–1: Merger & Acquisitions in the Global Vaccines Market
Table 9–2: Collaboration Deal in the Global Vaccines Market
Table 9–3: Licensing Agreement in the Global Vaccines Market
Table 9–4: Exclusive Agreement in the Global Vaccines Market
Table 9–5: Distribution Agreement in the Global Vaccines Market
Table 9–6: Partnerships in the Global Vaccines Market
Table 10–1: Sanofi Promising Vaccines in the Clinical Development
Table 10–2: GSK Promising Vaccines in the Clinical Development
Table 10–3: Merck Promising Vaccines in the Clinical Development
Table 10–4: Pfizer Promising Vaccines in the Clinical Development
Table 10–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development
Table 10–6: Emergent Biosolutions Promising Vaccines in the Clinical Development
Table 10–7: Valneva Promising Vaccines in the Clinical Development
Table 10–8: Seqirus Promising Vaccines in the Clinical Development
Table 10–9: Bavarian Nordic Promising Vaccines in the Clinical Development
Table 10–10: Sinovac Promising Vaccines in the Clinical Development
Table 10–11: Panacea Biotec Promising Vaccines in the Clinical Development
Table 10–12: Bharat Biotech Promising Vaccines in the Clinical Development
Table 11–1: Vaccitech Promising Vaccines in the Clinical Development
Table 11–2: Janssen Promising Vaccines in the Clinical Development
Table 11–3: Novavax Promising Vaccines in the Clinical Development
Table 11–4: VBI Vaccines Promising Vaccines in the Clinical Development
Table 11–5: GeoVax Promising Vaccines in the Clinical Development
Table 11–6: Moderna Promising Vaccines in the Clinical Development
Table 11–7: Biondvax Promising Vaccines in the Clinical Development
Table 11–8: Integrated Biotherapeutics Promising Vaccines in the Clinical Development
Table 11–9: GeneOne Life Science Promising Vaccines in the Clinical Development
Table 11–10: Profectus BioSciences Promising Vaccines in the Clinical Development
Table 11–11: Pneumagen Promising Vaccines in the Clinical Development
Table 11–12: Themis Bioscience Promising Vaccines in the Clinical Development
Table 11–13: Xeme Biopharma Promising Vaccines in the Clinical Development
Table 11–14: Altimmune Vaccines Promising Vaccines in the Clinical Development
Table 11–15: Pfenex Inc Promising Vaccines in the Clinical Development
Table 11–16: Northwest Biotherapeutics Promising Vaccines in the Clinical Development
Table 11–17: OncoBioMune Pharmaceuticals Promising Vaccines in the Clinical Development

List of Figures:

Figure 2–1: Global Vaccines Market Size (Million US$),2015 – 2018
Figure 2–2: Global Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 3–1: Global Vaccines Market Share, By Disease Indication (Percent),2018
Figure 3–2: Global Vaccines Market Share, By End User (Percent),2018
Figure 3–3: Global Vaccines Market Share by Brand (Percent), 2018
Figure 3–4: Global Vaccines Market Share by Company (Percent), 2018
Figure 5–1: Global Vaccines Market for Pneumococcal Disease (Million US$),2015 – 2018
Figure 5–2: Global Vaccines Market for Pneumococcal Disease Forecast (Million US$),2019 – 2025
Figure 5–3: Global Vaccines Market for DTP Disease (Million US$),2015 – 2018
Figure 5–4: Global Vaccines Market for DTP Disease Forecast (Million US$),2019 – 2025
Figure 5–5: Global Vaccines Market for Influenza Disease (Million US$),2015 – 2018
Figure 5–6: Global Vaccines Market for Influenza Disease Forecast (Million US$),2019 – 2025
Figure 5–7: Global Vaccines Market for HPV Disease (Million US$),2015 – 2018
Figure 5–8: Global Vaccines Market for HPV Disease Forecast (Million US$),2019 – 2025
Figure 5–9: Global Vaccines Market for Meningococcal Disease (Million US$),2015 – 2018
Figure 5–10: Global Vaccines Market for Meningococcal Disease Forecast (Million US$),2019 – 2025
Figure 5–11: Global Vaccines Market for Hepatitis Disease (Million US$),2015 – 2018
Figure 5–12: Global Vaccines Market for Hepatitis Disease Forecast (Million US$),2019 – 2025
Figure 5–13: Global Vaccines Market for MMR Disease (Million US$),2015 – 2018
Figure 5–14: Global Vaccines Market for MMR Disease Forecast (Million US$),2019 – 2025
Figure 5–15: Global Vaccines Market for Rotavirus Disease (Million US$),2015 – 2018
Figure 5–16: Global Vaccines Market for Rotavirus Disease Forecast (Million US$),2019 – 2025
Figure 5–17: Global Vaccines Market for Varicella Disease (Million US$),2015 – 2018
Figure 5–18: Global Vaccines Market for Varicella Disease Forecast (Million US$),2019 – 2025
Figure 5–19: Global Vaccines Market for Other Diseases (Million US$),2015 – 2018
Figure 5–20: Global Vaccines Market for Other Diseases Forecast (Million US$),2019 – 2025
Figure 6–1: Global Vaccines Market for Pediatric (Million US$),2015 – 2018
Figure 6–2: Global Vaccines Market for Pediatric Forecast (Million US$),2019 – 2025
Figure 6–3: Global Vaccines Market for Adult (Million US$),2015 – 2018
Figure 6–4: Global Vaccines Market for Adult Forecast (Million US$),2019 – 2025
Figure 7–1: GlobalPrevnar/Prevnar 13 Market Value (Million US$),2015–2018
Figure 7–2: Global Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025
Figure 7–3: GlobalGardasil/Gardasil 9 Market Value (Million US$),2015–2018
Figure 7–4: GlobalGardasil/Gardasil 9 Market Value Forecast (Million US$),2019–2025
Figure 7–5: Global Vaxigrip Market Value (Million US$),2015 – 2018
Figure 7–6: Global Vaxigrip Market Value Forecast (Million US$),2019 – 2025
Figure 7–7: Global Fluzone Market Value (Million US$),2015–2018
Figure 7–8: Global Fluzone Market Value Forecast (Million US$),2019–2025
Figure 7–9: Global Flublok Market Value & Forecast (Million US$),2018– 2025
Figure 7–10: Global Varivax Market Value (Million US$),2015–2018
Figure 7–11: Global Varivax Market Value Forecast (Million US$),2019–2025
Figure 7–12: Global Menactra Market Value (Million US$),2015–2018
Figure 7–13: Global Menactra Market Value Forecast (Million US$),2019–2025
Figure 7–14: Global Proquad Market Value (Million US$),2015–2018
Figure 7–15: Global Proquad Market Value Forecast (Million US$),2019–2025
Figure 7–16: Global Pneumovax 23 Market Value (Million US$),2015–2018
Figure 7–17: Global Pneumovax 23 Market Value Forecast (Million US$),2019–2025
Figure 7–18: Global Fluarix/FluLaval Market Value (Million US$),2015–2018
Figure 7–19: Global Fluarix/FluLaval Market Value Forecast (Million US$),2019–2025
Figure 7–20: Global Havrix/Twinrix/Engerix–B Market Value (Million US$),2015–2018
Figure 7–21: Global Havrix/Twinrix/Engerix–B Market Value Forecast (Million US$),2019–2025
Figure 7–22: Global Priorix, Priorix Tetra, Varilrix Market Value (Million US$),2015 – 2018
Figure 7–23: Global Priorix, Priorix Tetra, Varilrix Market Value Forecast (Million US$),2019 – 2025
Figure 7–24: Global M–M–R ll Market Value (Million US$),2015–2018
Figure 7–25: Global M–M–R ll Market Value Forecast (Million US$),2019–2025
Figure 7–26: Global Adacel Market Value (Million US$),2015–2017
Figure 7–27: Global Adacel Market Value Forecast (Million US$),2018–2025
Figure 7–28: Global Boostrix Market Value (Million US$),2015–2018
Figure 7–29: Global Boostrix Market Value Forecast (Million US$),2019–2025
Figure 7–30: Global Bexsero Market Value (Million US$),2015–2018
Figure 7–31: Global Bexsero Market Value Forecast (Million US$),2019–2025
Figure 7–32: Global Menveo Market Value (Million US$),2015–2018
Figure 7–33: Global Menveo Market Value Forecast (Million US$),2019–2025
Figure 7–34: Global Cervarix Market Value (Million US$),2015 – 2018
Figure 7–35: Global Cervarix Market Value Forecast (Million US$),2019 – 2025
Figure 7–36: Global Trumenba Market Value (Million US$),2016–2018
Figure 7–37: Global Trumenba Market Value Forecast (Million US$),2019–2025
Figure 7–38: Global Shingrix Market Value& Forecast (Million US$),2017–2018
Figure 7–39: Global Shingrix Market Value & Forecast (Million US$),2019 – 2025
Figure 7–40: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value (Million US$),2015–2018
Figure 7–41: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value Forecast (Million US$),2018 – 2025
Figure 7–42: Global Rotateq Market Value (Million US$),2015 – 2018
Figure 7–43: Global Rotateq Market Value Forecast (Million US$),2019 – 2025
Figure 7–44: Global Zostavax Market Value (Million US$),2015 – 2018
Figure 7–45: Global Zostavax Market Value Forecast (Million US$),2019 – 2025
Figure 7–46: Global Rotarix Market Value (Million US$),2015 – 2018
Figure 7–47: Global Rotarix Market Value Forecast (Million US$),2019 – 2025
Figure 7–48: Global Synflorix Market Value (Million US$),2015 – 2018
Figure 7–49: Global Synflorix Market Value Forecast (Million US$),2019 – 2025
Figure 7–50: Global Pediarix/Infanrix Market Value (Million US$),2015 – 2018
Figure 7–51: Global Pediarix/Infanrix Market Value Forecast (Million US$),2019 – 2025
Figure 7–52: Global Ticovac Market Value (Million US$),2015 – 2018
Figure 7–53: Global Ticovac Market Value Forecast (Million US$),2019 – 2025
Figure 7–54: Global Biken Ha Market Value (Million US$),2015 – 2018
Figure 7–55: Global Biken Ha Market Value Forecast (Million US$),2019– 2025
Figure 7–56: Global Tetrabik Market Value (Million US$),2015 – 2018
Figure 7–57: Global Tetrabik Market Value Forecast (Million US$),2019 – 2025
Figure 7–58: Global Mearubik Market Value (Million US$),2015 – 2018
Figure 7–59: Global Mearubik Market Value Forecast (Million US$),2019 – 2025
Figure 7–60: Global Varicella (MTP) Market Value (Million US$),2015 – 2018
Figure 7–61: Global Varicella (MTP) Market Value Forecast (Million US$),2019 – 2025
Figure 7–62: Global Jebik V Market Value (Million US$),2015 – 2018
Figure 7–63: Global Jebik V Market Value Forecast (Million US$),2019 – 2025
Figure 7–64: Global FluMist/Fluenz Market Value (Million US$),2015 – 2018
Figure 7–65: Global FluMist/Fluenz Market Value Forecast (Million US$),2019 – 2025
Figure 7–66: Global BioThrax Market Value (Million US$),2015 – 2018
Figure 7–67: Global BioThrax Market Value Forecast (Million US$),2019 – 2025
Figure 7–68: Global Dukoral Market Value (Million US$),2015 – 2018
Figure 7–69: Global Dukoral Market Value Forecast (Million US$),2019 – 2025
Figure 7–70: Global Ixiaro Market Value (Million US$),2015 – 2018
Figure 7–71: Global Ixiaro Market Value Forecast (Million US$),2019 – 2025
Figure 7–72: Global InLive Market Value (Million US$),2015 – 2018
Figure 7–73: Global InLive Market Value Forecast (Million US$),2019 – 2025
Figure 7–74: Global Healive Market Value (Million US$),2015 – 2018
Figure 7–75: Global Healive Market Value Forecast (Million US$),2019 – 2025
Figure 7–76: Global Bilive Market Value (Million US$),2015 – 2018
Figure 7–77: Global Bilive Market Value Forecast (Million US$),2019 – 2025
Figure 7–78: Global Anflu Market Value (Million US$),2015 – 2018
Figure 7–79: Global Anflu Market Value Forecast (Million US$),2019 – 2025
Figure 7–80: Global EasySix Market Value (Million US$),2015 – 2018
Figure 7–81: Global EasySix Market Value Forecast (Million US$),2019 – 2025
Figure 7–82: Global Imvamune Market Value (Million US$),2015 – 2018
Figure 7–83: Global Imvamune Market Value Forecast (Million US$),2019 – 2025
Figure 7–84: Global Other Vaccines Market Value (Million US$),2015 – 2018
Figure 7–85: Global Other Vaccines Market Value Forecast (Million US$),2019 – 2025
Figure 9–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–2: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2019 – 2025
Figure 9–3: GSK Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–4: GSK Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–5: Merck Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–6: Merck Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–7: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–8: Pfizer Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–9: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–10: AstraZeneca Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–11: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–12: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–13: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–14: Emergent Biosolutions Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–15: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–16: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–17: Valneva Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–18: Seqirus Vaccines Market Value Analysis (Million US$),2016 – 2018
Figure 9–19: Seqirus Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–20: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–21: Bavarian Nordic Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–22: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–23: Sinovac Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 9–24: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 9–25: Panacea Biotec Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

  • Global BCG Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Peptide Cancer Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
  • Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
  • Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......
  • Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
  • Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
  • Global BCG Vaccine Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Infectious Vaccine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs